Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01840228 · ClinicalTrials.gov registry record · NA
Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01840228 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 38 participants.
The verdict
NCT01840228, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Preterm birth, defined as birth before 37 weeks' gestation, is a leading cause of infant death and disease. Progesterone is the single most effective intervention in the prevention of preterm birth. However, current use of this therapy is limited to certain high-risk groups including women with a history of preterm birth and women with a short cervix. This study seeks to evaluate the efficacy of this preventive therapy in another high-risk group: women with arrested preterm labor. The investigators hypothesize that administration of vaginal progesterone in women who present with preterm labor but remain undelivered 12 hours after cessation of short-term therapy to inhibit contractions will result in lower rates of preterm birth before 37 weeks' than will administration of placebo.
Interventions
- DRUG Micronized progesterone suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01840228
The ClinicalTrials.gov registry entry for NCT01840228 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micronized progesterone suppository is the first listed.
NCT01840228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01840228 about?
NCT01840228 is a clinical study titled "Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor". Preterm birth, defined as birth before 37 weeks' gestation, is a leading cause of infant death and disease. Progesterone is the single most effective intervention in the prevention of preterm birth. However, current use of this therapy is limited to certain high-risk groups including women with a hi...
What is the current status of trial NCT01840228?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2013-05. Estimated completion is 2018-05-07.
What interventions are being tested in trial NCT01840228?
The interventions under investigation include: Micronized progesterone suppository (DRUG).
Who is sponsoring clinical trial NCT01840228?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.